Nebokitug, an anti-CCL24 monoclonal antibody, in patients with primary sclerosing cholangitis: A phase 2 study. Bowlus CL, Thorburn D, Barclay ST, Joshi D, et al. Am J Gastroenterol 2025 Nov 19. doi: 10.14309/ajg.0000000000003853.

Read + Share

Amedeo Smart

Independent Medical Education

Bowlus CL, Thorburn D, Barclay ST, Joshi D, et al. Nebokitug, an anti-CCL24 monoclonal antibody, in patients with primary sclerosing cholangitis: A phase 2 study. Am J Gastroenterol 2025 Nov 19. doi: 10.14309/ajg.0000000000003853.
PMID: 41257532